{
  "compound_id": "DB00188",
  "compound_name": "Bortezomib",
  "compound_percentile": 0.845588235294118,
  "disease_id": "DOID:11054",
  "disease_name": "urinary bladder cancer",
  "disease_percentile": 0.9148244473342,
  "metapath_contribution": {
    "CbGbCtD": 0.5106919812719009,
    "CbGdCrCtD": 0.0027632713885071907,
    "CbGeAlD": 0.10456068379757752,
    "CbGpPWpGaD": 0.17248299641676282,
    "CcSEcCtD": 0.20584269055789314,
    "CrCbGaD": 0.003658376567358601
  },
  "n_trials": 0.0,
  "prediction": 0.00384348524623205,
  "status": 0,
  "training_prediction": 0.009814755712301379
}